Adagloxad simolenin

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAdagloxad simolenin
Drug Alias NameGlobo H-KLHGlobo-H vaccineUCG949AA7ZOPT-822/OPT-821OPT-822/821 +[9] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsTriple Negative Breast NeoplasmsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineTaiwan +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer CenterObi Pharma Inc
Inactive CompaniesZuellig Pharma IncIqvia Rds (Shanghai) Co LtdMackay Memorial Hospital Inc +[5] 
Active IndicationsTriple Negative Breast NeoplasmsNeuroblastoma
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A